Moneycontrol PRO
Upcoming Webinar:Watch a panel of experts discuss: Challenges of continuously evolving regulation for Cryptocurrency, on 7th July at 3pm. Register Now
you are here: HomeNewsIndia

AP completes 80 lakh COVID-19 sample tests

It said 3,708 patients had recovered from the infection while 14 more succumbed in 24 hours.

October 31, 2020 / 07:14 PM IST

Andhra Pradesh on Saturday completed 80 lakh sample tests for coronavirus, which turned out a total of 8,23,348 positives so far. The state also crossed the 1.50 lakh mark in tests per million with an overall positivity rate of 10.25 percent. In 24 hours ending 9 am on Saturday, 82,045 tests were done, yielding 2,783 fresh cases of COVID-19, the latest bulletin said.

It said 3,708 patients had recovered from the infection while 14 more succumbed in 24 hours.

The number of active cases fell below the 25,000 mark to24,575, after a total of 7,92,083 recoveries and 6,690 deaths.

The overall COVID-19 recovery rate improved to 96.20 percent while the mortality rate remained stable at 0.81 percent. West Godavari and Krishna districts reported more than 400 new cases, while East Godavari, Guntur and Chittoor added between 300 and 400.

Four districts added between 100 and 200 more cases while four others reported less than 100 in 24 hours, it added.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Kurnool added the lowest 34 cases. Chittoor and Krishna saw three fresh coronavirus fatalities each and Guntur, Visakhapatnam and West Godavari two each.

Anantapuramu and East Godavari reported one more death each.
first published: Oct 31, 2020 07:14 pm
ISO 27001 - BSI Assurance Mark